Proteome‐Wide Genetic Study Identified ENTPD5 as a Candidate Target for Obesity‐Related MASLD
ABSTRACT Objective This study aimed to discover causal plasma proteins for metabolic dysfunction‐associated steatotic liver disease (MASLD) using trans‐ancestry genetic data. Methods We performed proteome‐wide Mendelian randomization (MR) for 1256 proteins and MASLD using genome‐wide association data from East Asian ( n = 85,124) and European ( n = 500,348) populations. Colocalization was conducted to validate putative causal proteins for MASLD, followed by two‐step MR assessing adiposity mediation. Longitudinal cross‐lagged analysis in a bariatric surgery cohort ( n = 53) was used to assess temporal associations. Results ENTPD5 and APOE showed consistent causal effects in both East Asians and Europeans, both supported by colocalization. Both proteins influenced MASLD risk through adiposity, with BMI mediating 15.7% of the ENTPD5 effect. Longitudinal analysis in the bariatric surgery cohort supported the temporal pathway “ENTPD5→BMI reduction→MASLD remission (assessed by the fatty liver index),” with 29.2% mediation by BMI. Phenome‐wide MR revealed a broad pleiotropic profile of ENTPD5, warranting further evaluation of target safety and repurposing potential. Conclusions These findings suggest that ENTPD5 and APOE are potential causal biomarkers for MASLD and may contribute to its pathogenesis. ENTPD5 represents a candidate target for obesity‐related diseases, although its pleiotropic profile warrants further investigation.
Authors
- Daniel Avery (ORCID: https://orcid.org/0000-0002-9823-9575)
- Ling Yang (ORCID: https://orcid.org/0000-0001-5750-6588)
- Dianjianyi Sun (ORCID: https://orcid.org/0000-0003-3651-6693)
- Canqing Yu (ORCID: https://orcid.org/0000-0002-0019-0014)
- Pang Yao (ORCID: https://orcid.org/0000-0002-6875-7435)
- Iona Y. Millwood (ORCID: https://orcid.org/0000-0002-0807-0682)
- Robin G. Walters (ORCID: https://orcid.org/0000-0002-9179-0321)
- Zhiyu Wu
- Xinyao Wang (ORCID: https://orcid.org/0000-0001-5468-3167)
- Huaidong Du (ORCID: https://orcid.org/0000-0002-9814-0049)
- Yuanjie Pang (ORCID: https://orcid.org/0000-0002-4826-8861)
- Liming Li (ORCID: https://orcid.org/0000-0001-5873-7089)
- Zhongtao Zhang (ORCID: https://orcid.org/0000-0002-8291-4097)
- Yang Liu (ORCID: https://orcid.org/0000-0002-4467-6358)
- Huajing Yu (ORCID: https://orcid.org/0009-0007-4163-1369)
- Junshi Chen (ORCID: https://orcid.org/0000-0001-5530-1343)
- Jun Lv (ORCID: https://orcid.org/0000-0001-7916-3870)
- Pei Pei (ORCID: https://orcid.org/0000-0002-5741-6563)
- Ting Wu
- Yating Huang
- Mengyi Li
- Yiping Chen
- Peng Zhang
- the China Kadoorie Biobank Collaborative Group
- Zhengming Chen
- Yuan Cao
Institutions
- Capital Medical University (CN)
- Peking University (CN)
- University of Oxford (GB)
- National Clinical Research Center for Digestive Diseases (CN)
- China National Center for Food Safety Risk Assessment (CN)
- Beijing Friendship Hospital (CN)
Publication Details
- Journal
- Obesity
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1002/oby.70323
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00